Monoclonal gammopathy of undetermined significance - Wikipedia
Long-Term Follow-up of Monoclonal Gammopathy of Undetermined Significance | NEJM
Laboratory testing requirements for diagnosis and follow-up of multiple myeloma and related plasma cell dyscrasias
The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the European Myeloma Network | Haematologica
Minimal Residual Disease Negativity Does Not Overcome Poor Prognosis in High-Risk Multiple Myeloma: A Single-Center Retrospective Study - Clinical Lymphoma, Myeloma and Leukemia
Monoclonal gammopathy of renal significance: Early diagnosis is key | Nefrología
Rheumatologic diseases impact the risk of progression of MGUS to overt multiple myeloma - ScienceDirect
Monoclonal Gammopathy of Undetermined Significance (MGUS)
Monoclonals - an overview | ScienceDirect Topics
IgM-MGUS and associated membranoproliferative glomerulonephritis during IVIG administration | SpringerLink
Monoclonal Gammopathy of Undetermined Significance (MGUS)
Secondary MGUS after autologous hematopoietic progenitor cell transplantation in plasma cell myeloma: a matter of undetermined significance | Bone Marrow Transplantation
Cutaneous manifestations of monoclonal gammopathy | Blood Cancer Journal
Monoclonal gammopathy of undetermined significance: A primary care guide | Cleveland Clinic Journal of Medicine
What is the significance of monoclonal gammopathy of undetermined significance? | RCP Journals
Prevalence of monoclonal gammopathies and clinical outcomes in a high-risk US population screened by mass spectrometry: a multicentre cohort study - The Lancet Haematology
The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the European Myeloma Network | Haematologica
Cancers | Free Full-Text | Monoclonal Gammopathy of Undetermined Significance (MGUS)—Not So Asymptomatic after All | HTML
Detection and prevalence of monoclonal gammopathy of undetermined significance: a study utilizing mass spectrometry-based monoclonal immunoglobulin rapid accurate mass measurement | Blood Cancer Journal
IJMS | Free Full-Text | Prevention Is the Best Treatment: The Case for Understanding the Transition from Monoclonal Gammopathy of Undetermined Significance to Myeloma | HTML
Contributions of the Bone Microenvironment to Monoclonal Gammopathy of Undetermined Significance Pathogenesis | SpringerLink
Comparison of MGUS and multiple myeloma variants | Download Table
Prevalence of Monoclonal Gammopathy of Undetermined Significance | NEJM
Absolute Risk of Progression of MGUS to Myeloma or Related Disorders... | Download Table
Prognosis of young patients with monoclonal gammopathy of undetermined significance (MGUS) | Blood Cancer Journal
